Blemish Control Dots

Description

24PATCHES BLEMISH DOTS are formulated as patches containing Aloe Vera as the active ingredient. Each carton contains a total quantity of 0.545 units. The product is designed for topical application and is packaged in a carton. The media type associated with this product is image/jpeg.

Uses and Indications

This drug is indicated for the soothing and reduction of redness and irritation associated with blemished skin. It is designed to absorb excess oil, thereby promoting faster healing of affected areas.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

Healthcare professionals are advised to instruct patients to begin by cleansing and drying the face thoroughly, ensuring that any makeup is completely removed. Following this preparation, patients should apply one healing dot, ensuring the sticky side is placed directly over the blemish.

The healing dot should be left in place for a minimum of 6 hours, although overnight application is recommended for optimal results. Patients may repeat this process as necessary, using a new healing dot for each application.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance should be sought or contact with a Poison Control center is advised.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid concurrent use of this product with other topical acne medications, as this may increase the likelihood of skin irritation and dryness. In the event of irritation, it is recommended that patients limit their use to one topical acne medication at a time.

The ingredients in this formulation adhere to the highest quality standards; however, sensitivity reactions may occur in rare instances. Should any signs of sensitivity arise, patients must discontinue use immediately and seek appropriate medical advice.

In cases of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control center without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. The use of this product in conjunction with other topical acne medications may increase the likelihood of skin irritation and dryness. In the event that irritation occurs, it is recommended that patients limit their use to one topical acne medication at a time to mitigate these effects.

While the ingredients in this product are formulated to meet high-quality standards, there may be infrequent instances of sensitivity. Should any sensitivity reactions occur, patients are advised to discontinue use immediately.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of additional topical agents is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Blemish Control Dots (salicylic acid 0.5%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

There is no specific information regarding the use of Blemish Control Dots (Aloe Vera - salicylic acid 0.5% patch) in lactating mothers or lactation considerations. The prescribing information does not address the excretion of the active ingredients in breast milk or any potential effects on breastfed infants. Healthcare professionals should exercise caution and consider the lack of data when advising lactating mothers on the use of this product.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data regarding its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

The ingredients used in this product meet the highest standards of quality. Instances of sensitivity have been reported; in such cases, it is advised to discontinue use immediately.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control center immediately. This precaution is crucial to ensure the safety and well-being of children who may inadvertently access the medication.

Storage and Handling

The product is supplied in its original packaging, which should be retained until the time of use to ensure optimal integrity. It is essential to store the patches at room temperature, away from direct light exposure to maintain their effectiveness. Once opened, the patches must be discarded to prevent any potential degradation or contamination.

Additional Clinical Information

The product is administered topically and is intended for external use only. Patients should be advised that the likelihood of skin irritation and dryness increases if another topical acne medication is used concurrently. In the event of irritation, it is recommended to use only one topical acne medication at a time. The formulation contains high-quality ingredients, and while sensitivity is rare, patients should discontinue use immediately if such a reaction occurs. Additionally, the product should be kept out of reach of children, and if ingested, medical assistance or contact with a Poison Control center is necessary.

Drug Information (PDF)

This file contains official product information for Blemish Control Dots, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)